Programme

<p> Born in Moscow, Russia on 27 August 1979.Graduated from the State University “Higher School of Economics”, Diploma in Economy and Business Administration.Since 1995 in Healthcare and Pharmaceutics.R-Pharm Founder. President of All-Russia Business Association “Delovaya Rossiya” (“Business Russia”), actively participating in the improvement of investment climate in the Russian Federation and the establishment of the regional investment standard.Member of the Economic Council under the President of the Russian Federation.Member of the Presidential Council for Priority National Projects and Demographic Policy.Member of the Expert Council under the Government of the Russian Federation. Member of the Public Chamber of the Russian Federation, Head of Commission on Investment Climate.Representative (public ombudsman) of the Commissioner of the Presidential Council on the protection of the rights of entrepreneurs on issues related to the protection of the rights of foreign investors.Board-member and Co-chairman of Committee of the Russian Union of Industrialists and Entrepreneurs on pharmaceutical and medical industry.Co-Chairman of the National Rating CommitteeMember of the Public Council under the Ministry of Industry and Trade of the Russian Federation (pharmaceutical, medical equipment and technologies).Member of the Supervisory Board of the Autonomous Nonprofit Organization "Agency for Strategic Initiatives". </p>

Prior to joining Sapinda, Mr Volynets was the CEO of EN+ Group (a leading global metals, energy and mining group). Mr Volynets moved to EN+ in 2010 from UC RUSAL, where he held the position of Deputy CEO responsible for Strategy and M&A. Before that he held the position of Chief Development Officer at SUAL International. Mr Volynets started his professional career at Monitor Group in Boston and London. Mr Volynets was educated at the Moscow State University and the American University Washington D.C. and holds an MBA degree from Georgetown University & INSEAD.

<p> Born in Moscow, Russia on 27 August 1979.Graduated from the State University “Higher School of Economics”, Diploma in Economy and Business Administration.Since 1995 in Healthcare and Pharmaceutics.R-Pharm Founder. President of All-Russia Business Association “Delovaya Rossiya” (“Business Russia”), actively participating in the improvement of investment climate in the Russian Federation and the establishment of the regional investment standard.Member of the Economic Council under the President of the Russian Federation.Member of the Presidential Council for Priority National Projects and Demographic Policy.Member of the Expert Council under the Government of the Russian Federation. Member of the Public Chamber of the Russian Federation, Head of Commission on Investment Climate.Representative (public ombudsman) of the Commissioner of the Presidential Council on the protection of the rights of entrepreneurs on issues related to the protection of the rights of foreign investors.Board-member and Co-chairman of Committee of the Russian Union of Industrialists and Entrepreneurs on pharmaceutical and medical industry.Co-Chairman of the National Rating CommitteeMember of the Public Council under the Ministry of Industry and Trade of the Russian Federation (pharmaceutical, medical equipment and technologies).Member of the Supervisory Board of the Autonomous Nonprofit Organization "Agency for Strategic Initiatives". </p>

Brian Leach assumed the role of Chief Risk Officer in March 2008. Prior to becoming Citi's Chief Risk Officer, Brian was the co-COO of Old Lane. Brian co-founded Old Lane LP in 2005. Earlier, he had worked at Morgan Stanley, finishing as Risk Manager of the Institutional Securities Business. As Risk Manager, he oversaw capital allocation, and all aspects of credit, market, and operational risk management. He was a member of Morgan Stanley's Institutional Securities Division Management Group, Co-Chairman of the Capital Commitment Committee, and Chairman of the Board of Trustees of the Morgan Stanley Foundation. From October 1998 to December 1999, Brian was seconded to Long-Term Capital Management, the Greenwich, Connecticut-based hedge fund. He was one of 6 managers selected from a consortium of 14 global financial institutions to manage the liquidation of LTCM. Upon his return, he was given the responsibility as the Chief Operating Officer for the Fixed Income Division, where he had broad oversight responsibilities for the division's risk, operations, and legal issues. Brian has a BA in economics from Brown University and an MBA from Harvard Business School.

Jim is chairman of Goldman Sachs Asset Management (GSAM). As chairman, he is involved in helping guide all aspects of GSAM’s business around the world. Prior to assuming this role in September 2010, Jim was head of Global Economics, Commodities and Strategy Research. Jim is the creator of the acronym BRICs. Together with his colleagues, he has published much research about BRICs, which has become synonymous with the emergence of Brazil, Russia, India and China as the growth opportunities of the future. Jim earned a degree in economics from Sheffield University in 1978 and a PhD from the University of Surrey in 1982. He received an honorary doctorate from the Institute of Education, University of London, in 2009 for his educational philanthropy.

<p> Born in Moscow, Russia on 27 August 1979.Graduated from the State University “Higher School of Economics”, Diploma in Economy and Business Administration.Since 1995 in Healthcare and Pharmaceutics.R-Pharm Founder. President of All-Russia Business Association “Delovaya Rossiya” (“Business Russia”), actively participating in the improvement of investment climate in the Russian Federation and the establishment of the regional investment standard.Member of the Economic Council under the President of the Russian Federation.Member of the Presidential Council for Priority National Projects and Demographic Policy.Member of the Expert Council under the Government of the Russian Federation. Member of the Public Chamber of the Russian Federation, Head of Commission on Investment Climate.Representative (public ombudsman) of the Commissioner of the Presidential Council on the protection of the rights of entrepreneurs on issues related to the protection of the rights of foreign investors.Board-member and Co-chairman of Committee of the Russian Union of Industrialists and Entrepreneurs on pharmaceutical and medical industry.Co-Chairman of the National Rating CommitteeMember of the Public Council under the Ministry of Industry and Trade of the Russian Federation (pharmaceutical, medical equipment and technologies).Member of the Supervisory Board of the Autonomous Nonprofit Organization "Agency for Strategic Initiatives". </p>